FDA Announces Hearing on Genetically Engineered Salmon Labeling
The Food and Drug Administration is announcing a public hearing on September 21, 2010 in Rockville, MD regarding the labeling of food derived from AquAdvantage Salmon, a genetically engineered Atlantic salmon.
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.